Leader in surgical planning and navigation, robotic digital microscopy and data platforms, Synaptive Medical, has announced the completion of a sale of preferred equity totaling $17,000,000 USD. The investment was made by Sensegain Group, a leading asset management firm in China. Ms. Jing Yang, Board Member & Senior Partner of Sensegain, will join Synaptive’s Board of Directors.
Sensegain Group is headquartered in Beijing with multiple locations globally and has developed a strong partnership with industry leaders, as well as deep insights into sectors including TMT, Healthcare, and Advanced Manufacturing in China, United States, Canada, Israel, and other countries. Sensegain maintains a value investment principle and “Global + China” beliefs that help to maximize the value of portfolio companies and partners internationally. Synaptive management team worked tightly with Sensegain Group international team and the two parties are of great confidence that this investment will serve as a bright start of a long-term collaboration with each other.
This funding will enable Synaptive to further expand the availability of its suite of fully automated and integrated hardware and software products that enhance healthcare providers’ capabilities in diagnostic imaging, as well as surgical planning, navigation and visualization in the neurological and orthopedic spaces. Synaptive’s products have been uniquely designed to optimize workflow and enhance medical decision-making to improve patient outcomes.
In addition, Synaptive is announcing a new distribution partnership with Cicel Science and Technology Company, Ltd. of Beijing, for entry into the China market.
Marc Buntaine, CEO of Synaptive Medical, stated, “This investment is a testament to the confidence new investors have in Synaptive’s mission to provide state-of-the-art products that enable surgeons and healthcare professionals to provide safer patient-specific care in highly delicate cranial or spinal procedures for neurological disorders or injuries each year. With this financing, we are further committed to broadening the availability of our product offering to enter the greater China market with our new partner, Cicel.”
Cameron Piron, president and co-founder of Synaptive Medical, added, “We are excited to bring a new board member to our group with a strong background in finance and the China market.”
Synaptive offers products which provide world-class MRI cranial imaging, enhanced surgical planning, visualization both before and during surgery, and efficient data management throughout the clinical workflow, including medical informatics AI research. Synaptive’s products are modular and designed for seamless integration both within the Synaptive suite and with other products, so hospitals may purchase Synaptive offerings either individually or together, to best suit their needs.